Skip to main content

Laura Lovett

By Laura Lovett | 04:54 pm | June 13, 2018
A little bit of cash paired with a wearable activity tracker could be key in motivating people with ischemic heart disease to stay active.
By Laura Lovett | 12:38 pm | June 13, 2018
Paradromics, a San Jose, California-based startup that is working to create streaming capabilities between the brain and computers, has just landed $7 million in seed funding.
By Laura Lovett | 05:26 pm | June 12, 2018
Biogen has just launched a new app, called Aby, aimed at giving people living with multiple sclerosis (MS) accurate and reliable information about the condition and support.
By Laura Lovett | 05:15 pm | June 12, 2018
A clinical review, published in Evidence Based Mental Health Month, suggests numerous issues, including poor app design and privacy concerns, have contributed to a low engagement rate for mental health apps.
By Laura Lovett | 05:13 pm | June 11, 2018
Glooko announced the launch of the new version of its Glooko Web Application platform this morning.
By Laura Lovett | 04:05 pm | June 11, 2018
Paris-based Sensome, a company that makes sensors to identify biological tissues, just landed $5.
By Laura Lovett | 01:10 pm | June 11, 2018
As Pharma giant Roche continues its dive into the digital health realm, it is releasing a new self-testing device for INR or blood coagulation levels, that can wirelessly connect to a smartphone app.
By Laura Lovett | 03:16 pm | June 08, 2018
The road to digital innovation in the pharma and healthcare space is going to take players across industries — from tech developers and engineers to researchers and clinicians, according to a panel of digital-focused VPs speaking at BIO 2018 in Boston.
By Laura Lovett | 05:39 pm | June 07, 2018
A drug no longer needs to be a tangible object, according to panelist at the BIO 2018 convention in Boston.
By Laura Lovett | 02:49 pm | June 07, 2018
Kibbutz Shefayim Israel-based deep learning startup Zebra Medical Vision has just closed a $30 million Series C funding round led by aMoon and Aurum Ventures with participation from Johnson & Johnson Innovation JJDC and Intermountain Healthcare.